Biotechnology pioneer C. Randal Mills, Ph.D., appointed CEO
C. Randal “Randy” Mills, Ph.D., has been appointed chief executive officer of Sanford Burnham Prebys. Mills joins the Institute with decades of experience as an entrepreneur and transformational leader in the biomedical industry.
|
|
Nature study identifies 21 existing drugs that could treat COVID-19
Led by Sumit Chanda, Ph.D., a global team of scientists has analyzed the most comprehensive collection of known drugs for their ability to block replication of SARS-CoV-2, the virus that causes COVID-19. The researchers identified 21 drugs that would likely be safe and effective in patients. Multiple compounds were found to work synergistically with remdesivir, a current standard-of-care treatment for COVID-19. The study was published in
Nature.
|
|
A helping hand for cancer immunotherapy
Research from Ze'ev Ronai, Ph.D., suggests that PRMT5 inhibitors may turn “cold” tumors “hot,” making them responsive to immunotherapy. Since PRMT5 inhibitors are currently in clinical trials for some types of cancer, the discovery suggests that they should now be evaluated in tumors that are not responsive to immunotherapy. The study was published in
Science Translational Medicine.
|
|
New drug target for dry AMD identified
Francesca Marassi, Ph.D., has shown that the blood protein vitronectin is a promising drug target for dry age-related macular degeneration (AMD), a leading cause of vision loss in Americans 60 years of age and older. The discovery may lead to a therapy for the condition, which affects nearly 10 million people. The study was published in the
Proceedings of the National Academy of Sciences (PNAS).
|
|
CIRM award will use "mini lungs" to test potential COVID-19 treatments
Evan Snyder, M.D., Ph.D., has received a grant from the California Institute for Regenerative Medicine (CIRM) to use “mini lungs in a dish” to test two promising drug candidates for COVID-19. In addition to finding new treatments for COVID-19, the research may help us understand why some patients fare worse than others.
|
|
Padres Pedal the Cause awards three grants to Sanford Burnham Prebys scientists
Research into pediatric brain cancer, lung cancer and stomach cancer has accelerated thanks to new grants from Padres Pedal the Cause. The awards fund collaborative research for scientists at Sanford Burnham Prebys, Moores Cancer Center at UC San Diego Health and the Salk Institute.
|
|
American Cancer Society grants "rising star" award to Sanford Burnham Prebys scientist
Brooke Emerling, Ph.D., has received an American Cancer Society Research Scholar Grant—an often career-launching award for “rising stars” in the field. The award supports Emerling’s efforts to target and eliminate tumors that have a p53 mutation—the most altered gene in human cancers.
|
|
The latest news on the search for an Alzheimer's cure
The need for an effective Alzheimer’s treatment remains a priority for patients and caregivers worldwide. At Alzheimer's San Diego’s virtual research forum, Jerold Chun, Ph.D., and T.C. Chung, Ph.D., explained our current scientific understanding(s) of the disease and how close we are to developing potential therapies.
|
|
How scientists are unlocking the secrets of cellular aging
Aging is a biological reality with which we are all familiar. But how do we age at a molecular level? At a recent virtual lecture hosted by the Fleet Science Center, Malene Hansen, Ph.D., explained how she is unraveling the secrets of aging—in hopes of preventing age-related conditions such as cancer, diabetes and Alzheimer's disease.
|
|
Join us (virtually) for the 2020 Fishman Fund Awards ceremony celebrating exceptional postdocs
Each year, Sanford Burnham Prebys' exceptional postdoctoral scholars compete for coveted Fishman Fund Awards. These prestigious grants support the research of early career scientists and help them develop into the scientific leaders of tomorrow. Join Reena Horowitz and Jeanne Jones on Thursday, September 24, from 4:00 p.m. to 5:00 p.m. PT, to meet and celebrate this year's Fishman Fund Award winners.
|
|
How do we navigate life in the "new normal"? Ask our scientists the things you really want to know about COVID-19
A special COVID-19 webinar will feature Sumit Chanda, Ph.D., and Evan Snyder, M.D., Ph.D., who will share their latest research advances and answer your questions about life during the pandemic. This Bring It! Fireside Chat is tailored for audiences with questions about how to navigate life in the "new normal" and will be held Tuesday, August 25, from 2:00 p.m. to 3:00 p.m. PT.
|
|
At Sanford Burnham Prebys, we are passionate about finding bold new ways to treat disease, and we recognize the importance of sharing our discoveries with the public—especially during this unprecedented time. Find out where and when you can "meet" our scientists virtually and learn about their research in this
community event calendar.
|
|
Meet our new CEO, C. Randal "Randy" Mills, Ph.D., a biotechnology pioneer with decades of experience in the biomedical industry.
|
|
Sumit Chanda, Ph.D., explains why you may want to rethink catching a movie during the pandemic—even if the theater is open.
|
|
Double your COVID-19 donation
Only research will allow scientists to understand and stop COVID-19. We are hopeful that our work will emerge as part of the larger solution to this global health crisis, and we invite you to accelerate our progress and impact. If you donate today, your gift will be matched dollar for dollar—up to $500,000—thanks to the generosity of Dinah Conyers Ruch.
|
|
|
|
|
|
|
|
